Rabies: Underused vaccines, unnecessary deaths

Vaccine

Volumn 32, Issue 18, 2014, Pages 2017-2019

  Dodet, Betty ^a   Durrheim, David N ^b   Rees, Helen ^c  

^a Dodet Bioscience   (France)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

DOG BITE; EDITORIAL; HUMAN; INCUBATION TIME; POST EXPOSURE PROPHYLAXIS; PRE EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROPHYLAXIS; RABIES;

ANIMALS; CHILD; DOG DISEASES; DOGS; HUMANS; IMMUNIZATION PROGRAMS; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES;

EID: 84896545847     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.031     Document Type: Editorial

References (16)

1. Neville J. Rabies in the Ancient World. Historical Perspective of Rabies in Europe and the Mediterranean Basin. A testament to rabies by Dr Arthur King 2004, OIE-Veterinary Laboratories Agency, pp. 1, 13, 24. http://www.oie.int/doc/ged/D11246.PDF [accessed 05.11.13]. A.A. King, A.R. Fooks, M. Aubert, A.I. Wandeler (Eds.).
2. World Health Organization Rabies vaccines: WHO position paper. WER 2010, 32:309-320.
3. Hemachudha T., Ugolini G., Wacharapluesadee S., Sungkarat W., Shuangshoti S., Laothamatas J. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol 2013, 12:498-513.
4. World Health Organization WHO Expert Consultation on Rabies. Second Report. WHO Technical Report Series n° 982 2013, WHO.
5. Wu X., Smith T.G., Rupprecht C.E. From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines 2011, 10(11):1597-1608.
6. Knobel D.L., Cleaveland S., Coleman P.G. Re-evaluating the burden of rabies in Africa and Asia. Bull WHO 2005, 83:360-368.
7. World Health Organization Human and dog rabies prevention and control. Report of the WHO/Bill & Melinda Gates Foundation Consultation, Annecy, France, 7-9 October 2009 2010, WHO. http://whqlibdoc.who.int/hq/2010/WHO_HTM_NTD_NZD_2010.1_eng.pdf.
8. Malerczyk C., Vakil H.B., Bender W. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV). Hum Vaccin Immunother 2013, 9(7):1454-1459.
9. Liu Q., Ertl H. Preventative childhood vaccination to rabies. Expert Opin Biol Ther 2013, [in press].
10. Lang J., Hoa D.Q., Gioi N.V. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet 1997, 349:1663-1665.
11. Vien N.C., Feroldi E., Lang J. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans R Soc Trop Med Hyg 2008, 102(3):294-296.
12. Pengsaa K., Limkittikul K., Sabchareon A., Ariyasriwatana C., Chantanavich P., Attanath P., et al. A three-year clinical study on immunogenicnity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J 2009, 28(4):335-337.
13. Kamoltham T., Thinyounyong W., Phongchamnaphai P. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is imunogenic and safe. J Pediatr 2007, 151:173-177.
14. Chulasugandha P., Khawplod P., Havanond P., Wilde H. Cost comparison of rabies pre-exposure with post-exposure treatment in Thai children. Vaccine 2006, 34:14878-14882.
15. Black S. The role of health economic analyses in vaccine decision making. Vaccine 2013, [in press]. 10.1016/j.vaccine.2013.08.008.
16. Quiambao B.P. Rabies pre-exposure prophylaxis. 15th Pediatric Infectious Disease Society of the Philippines (PIDSP) Annual Convention 2008, [accessed 05.11.13]. http://www.pidsphil.org/pdfviewer.php%3Fid=15.